Clinical AI company Sensyne Health has signed a five-year strategic research agreement with Somerset NHS Foundation Trust.
The dataset covers just over one million unique patient records, with all data anonymised by Somerset beforehand.
This brings AIM-listed Sensyne’s total anonymised patient data available for analysis to 5.6 million patients.
Sensyne Health chief executive Lord (Paul) Drayson says: “This new agreement will enable research to improve patient care and accelerate medical research and by helping to grow our overall data set to over 5.6m patients, will now enable us to broaden our research and expand our therapeutic focus.”
Imagine your body with its exact organ systems, cells and DNA, existing in 1’s and 0’s, on a silicon chip. This is what you would call a virtual twin, and research in Oxford indicates how far away we are from creating such a digital entity.
An Oxford startup has developed measurement technology for the efficiency of drug loading in nanoparticles and for monitoring nitrates and phosphates in water.